Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells

Acta Biomaterialia

Volumn 9, Issue 11, 2013, Pages 9159-9168

  Wu, Chengtie ^a   Zhou, Yinghong ^b   Chang, Jiang ^a   Xiao, Yin ^b  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Dimethyloxallyl glycine; Drug delivery; Hypoxia; Scaffolds; Tissue engineering

Indexed keywords

BIOACTIVE GLASS; BIOACTIVITY; BONE; CELL ENGINEERING; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; ENDOTHELIAL CELLS; GENE EXPRESSION; MESOPOROUS MATERIALS; PHOSPHATASES; SCAFFOLDS (BIOLOGY); STABILIZATION; TARGETED DRUG DELIVERY; TISSUE REGENERATION;

ANGIOGENESIS; DIMETHYLOXALLYL GLYCINE; GLASS SCAFFOLDS; HUMAN BONE MARROW STROMAL CELLS; HYPOXIA; HYPOXIA-INDUCIBLE FACTORS; MESOPOROUS; MESOPOROUS BIOACTIVE GLASS; PROPERTY; TISSUES ENGINEERINGS;

AMINO ACIDS;

ALKALINE PHOSPHATASE; DIMETHYLOXALLYL GLYCINE; GLASS; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OSTEOCALCIN; OSTEOPONTIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; COMPETITIVE INHIBITION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; KNEE ARTHROPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STROMA CELL; TISSUE ENGINEERING;

LAKE VICTORIA MARBURGVIRUS;

DIMETHYLOXALLYL GLYCINE; DRUG DELIVERY; HYPOXIA; SCAFFOLDS; TISSUE ENGINEERING;

ADSORPTION; ALKALINE PHOSPHATASE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SHAPE; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLASS; GLYCINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NANOPORES; NEOVASCULARIZATION, PHYSIOLOGIC; NITROGEN; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; POROSITY; STROMAL CELLS; TEMPERATURE; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; X-RAY DIFFRACTION;

EID: 84885066888     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.06.026     Document Type: Article

References (52)

1. R. Langer, and J.P. Vacanti Tissue engineering Science 260 5110 1993 920 926 (Pubitemid 23209960)
2. K.E. Healy, and R.E. Guldberg Bone tissue engineering J Musculoskelet Neuronal Interact 7 4 2007 328 330
3. D.P. Pioletti, M.O. Montjovent, P.Y. Zambelli, and L. Applegate Bone tissue engineering using foetal cell therapy Swiss Med Wkly 137 Suppl. 155 2007 86S 89S (Pubitemid 46807657)
4. P.H. Chao, W. Grayson, and G. Vunjak-Novakovic Engineering cartilage and bone using human mesenchymal stem cells J Orthop Sci 12 4 2007 398 404 (Pubitemid 47174859)
5. M.W. Laschke, Y. Harder, M. Amon, I. Martin, J. Farhadi, and A. Ring Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes Tissue eng 12 8 2006 2093 2104 (Pubitemid 44734969)
6. P. Yilgor, K. Tuzlakoglu, R.L. Reis, N. Hasirci, and V. Hasirci Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering Biomaterials 30 21 2009 3551 3559
7. Tan Q, Chen B, Yan X, Lin Y, Xiao Z, Hou X, Dai J. Promotion of diabetic wound healing by collagen scaffold with collagen-binding vascular endothelial growth factor in a diabetic rat model. J Tissue Eng Regen Med; 2012; http://dx.doi.org/10.1002/term.1513.
8. S.M. Jay, and W.M. Saltzman Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking J Control Release 134 1 2009 26 34
9. K.Y. Lee, M.C. Peters, and D.J. Mooney Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice J Control Release 87 1-3 2003 49 56 (Pubitemid 36255446)
10. J.H. Kim, T.H. Kim, G.Z. Jin, J.H. Park, Y.R. Yun, J.H. Jang, and H.W. Kim Mineralized poly(lactic acid) scaffolds loading vascular endothelial growth factor and the in vivo performance in rat subcutaneous model J Biomed Mater Res A 101 5 2013 1447 1455
11. M.S. Kim, J.H. Lee, S.J. Kim, and H. Shin Composite fibrous matrices prepared by electrospinning with various volumes to control the amount of immobilized basic fibroblast growth factors and its in vitro bioactivity J Control Release 152 Suppl. 1 2011 e149 e151
12. F.R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J.J. Gavira, and T. Simon-Yarza Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J Control Release 147 1 2010 30 37
13. Y. Wang, X. Shi, L. Ren, Y. Yao, and D.A. Wang In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold J Biomater Sci Polym Ed 21 8-9 2010 1227 1238
14. C. Wu, Y. Zhu, J. Chang, Y. Zhang, and Y. Xiao Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability J Biomed Mater Res B Appl Biomater 94 1 2010 32 43
15. C. Wu, and H. Zreiqat Porous bioactive diopside (CaMgSi(2)O(6)) ceramic microspheres for drug delivery Acta Biomater 6 3 2010 820 829
16. X. Yan, X. Huang, C. Yu, H. Deng, Y. Wang, and Z. Zhang The in vitro bioactivity of mesoporous bioactive glasses Biomaterials 27 18 2006 3396 3403
17. X. Yan, C. Yu, X. Zhou, J. Tang, and D. Zhao Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities Angew Chem Int Ed Engl 43 44 2004 5980 5984 (Pubitemid 39551337)
18. M.A. Vallet-Regi, L. Ruiz-Gonzalez, I. Izquierdo-Barba, and J.M. Gonzalez-Calbet Revisiting silica based ordered mesoporous materials: medical applications J Mater Chem 16 1 2006 26 31 (Pubitemid 43324482)
19. M. Vallet-Regi, F. Balas, and D. Arcos Mesoporous materials for drug delivery Angew Chem Int Ed Engl 46 40 2007 7548 7558 (Pubitemid 47556998)
20. 5 system with tailored hierarchical meso-macroporosity Acta Biomater 7 3 2011 1265 1273
21. F. Balas, M. Manzano, P. Horcajada, and M. Vallet-Regi Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials J Am Chem Soc 128 25 2006 8116 8117 (Pubitemid 43967738)
22. X. Li, J. Shi, X. Dong, L. Zhang, and H. Zeng A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior J Biomed Mater Res A 84 1 2008 84 91 (Pubitemid 350244249)
23. C. Wu, Y. Ramaswamy, Y. Zhu, R. Zheng, R. Appleyard, and A. Howard The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(dl-lactide-co-glycolide) films Biomaterials 30 12 2009 2199 2208
24. C. Wu, Y. Zhang, Y. Zhou, W. Fan, and Y. Xiao A comparative study of mesoporous-glass/silk and non-mesoporous-glass/silk scaffolds: physiochemistry and in vivo osteogenesis Acta Biomater 7 5 2011 2229 2236
25. C. Wu, R. Miron, A. Sculeaan, S. Kaskel, T. Doert, and R. Schulze Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds Biomaterials 32 29 2011 7068 7078
26. C. Wu, Y. Zhang, Y. Zhu, T. Friis, and Y. Xiao Structure-property relationships of silk-modified mesoporous bioglass scaffolds Biomaterials 31 13 2010 3429 3438
27. C. Wu, Y. Luo, G. Cuniberti, Y. Xiao, and M. Gelinsky Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability Acta Biomater 7 6 2011 2644 2650
28. A. El-Fiqi, T.H. Kim, M. Kim, M. Eltohamy, J.E. Won, and E.J. Lee Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules Nanoscale 4 23 2012 7475 7488
29. C. Wu, W. Fan, M. Gelinsky, Y. Xiao, P. Simon, and R. Schulze Bioactive SrO-SiO(2) glass with well-ordered mesopores: characterization, physiochemistry and biological properties Acta Biomater 7 4 2011 1797 1806
30. Y.L. Hong, X.S. Chen, X.B. Jing, H.S. Fan, Z.W. Gu, and X.D. Zhang Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers Adv Funct Mater 20 9 2010 1501 1510
31. 2-regulated prolyl hydroxylation Science 292 5516 2001 468 472 (Pubitemid 32335942)
32. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 5545 2001 1337 1340 (Pubitemid 33063099)
33. 2 sensing Science 292 5516 2001 464 468 (Pubitemid 32335941)
34. C. Wu, W. Fan, Y. Zhu, M. Gelinsky, J. Chang, and G. Cuniberti Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure Acta Biomater 7 10 2011 3563 3572
35. 2 scaffolds with improved mineralization and cytocompatibility for drug delivery and bone tissue engineering J Mater Chem 21 2011 18300 18307
36. C. Wu, Y. Zhou, W. Fan, P. Han, J. Chang, and J. Yuen Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering Biomaterials 33 7 2012 2076 2085
37. C. Wu, Y. Ramaswamy, and H. Zreiqat Porous diopside (CaMgSi(2)O(6)) scaffold: a promising bioactive material for bone tissue engineering Acta Biomater 6 6 2010 2237 2245
38. Q.Z. Chen, I.D. Thompson, and A.R. Boccaccini 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering Biomaterials 27 11 2006 2414 2425 (Pubitemid 41821820)
39. D.W. Hutmacher Scaffolds in tissue engineering bone and cartilage Biomaterials 21 24 2000 2529 2543
40. T. Ukmar, U. Maver, O. Planinsek, V. Kaucic, M. Gaberscek, and A. Godec Understanding controlled drug release from mesoporous silicates: theory and experiment J Control Release 155 3 2011 409 417
41. Y. Zhu, Y. Zhang, C. Wu, Y. Fang, J. Wang, and S. Wang The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds Micropor Mesopor Mater 143 2011 311 319
42. W. Xia, and J. Chang Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system J Control Release 110 3 2006 522 530 (Pubitemid 43163442)
43. Y.F. Zhu, and S. Kaskel Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds Micropor Mesopor Mater 118 1-3 2009 176 182
44. A. Weidemann, and R.S. Johnson Biology of HIF-1alpha Cell Death Differ 15 4 2008 621 627
45. X. Hu, S.P. Yu, J.L. Fraser, Z. Lu, M.E. Ogle, and J.A. Wang Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis J Thorac Cardiovasc Surg 135 4 2008 799 808 (Pubitemid 351417929)
46. C. Wu, Y. Zhou, M. Xu, P. Han, L. Chen, and J. Chang Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity Biomaterials 34 2 2013 422 433
47. S. Hudecova, L. Lencesova, L. Csaderova, M. Sirova, D. Cholujova, and M. Cagala Chemically mimicked hypoxia modulates gene expression and protein levels of the sodium calcium exchanger in HEK 293 cell line via HIF-1alpha Gen Physiol Biophys 30 2 2011 196 206
48. D.C. Genetos, C.M. Lee, A. Wong, and C.E. Yellowley HIF-1alpha regulates hypoxia-induced EP1 expression in osteoblastic cells J Cell Biochem 107 2 2009 233 239
49. 2 composite bioceramics Acta Biomater 8 1 2012 350 360
50. L.L. Hench, and J.M. Polak Third-generation biomedical materials Science 295 5557 2002 1014 1017
51. H.W. Kim, H.E. Kim, and J.C. Knowles Production and potential of bioactive glass nanofibers as a next-generation biomaterial Adv Funct Mater 16 12 2006 1529 1535 (Pubitemid 44266040)
52. M. Wagegg, T. Gaber, F.L. Lohanatha, M. Hahne, C. Strehl, and M. Fangradt Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner PLoS One 7 9 2012 e46483